52 related articles for article (PubMed ID: 2837325)
1. Human Cancer and Platelet Interaction, a Potential Therapeutic Target.
Wang S; Li Z; Xu R
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29677116
[TBL] [Abstract][Full Text] [Related]
2. Platelet Integrins in Tumor Metastasis: Do They Represent a Therapeutic Target?
Lavergne M; Janus-Bell E; Schaff M; Gachet C; Mangin PH
Cancers (Basel); 2017 Sep; 9(10):. PubMed ID: 28956830
[TBL] [Abstract][Full Text] [Related]
3. Targeting Activated Platelets: A Unique and Potentially Universal Approach for Cancer Imaging.
Yap ML; McFadyen JD; Wang X; Zia NA; Hohmann JD; Ziegler M; Yao Y; Pham A; Harris M; Donnelly PS; Hogarth PM; Pietersz GA; Lim B; Peter K
Theranostics; 2017; 7(10):2565-2574. PubMed ID: 28819447
[No Abstract] [Full Text] [Related]
4. Interaction between circulating cancer cells and platelets: clinical implication.
Lou XL; Sun J; Gong SQ; Yu XF; Gong R; Deng H
Chin J Cancer Res; 2015 Oct; 27(5):450-60. PubMed ID: 26543331
[TBL] [Abstract][Full Text] [Related]
5. Platelet--cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation.
Jurasz P; Alonso-Escolano D; Radomski MW
Br J Pharmacol; 2004 Dec; 143(7):819-26. PubMed ID: 15492016
[TBL] [Abstract][Full Text] [Related]
6. Different adhesion properties of highly and poorly metastatic HT-29 colon carcinoma cells with extracellular matrix components: role of integrin expression and cytoskeletal components.
Haier J; Nasralla M; Nicolson GL
Br J Cancer; 1999 Aug; 80(12):1867-74. PubMed ID: 10471033
[TBL] [Abstract][Full Text] [Related]
7. Studies on tumor-cell-induced platelet aggregation in human lung cancer cell lines.
Heinmöller E; Weinel RJ; Heidtmann HH; Salge U; Seitz R; Schmitz I; Müller KM; Zirngibl H
J Cancer Res Clin Oncol; 1996; 122(12):735-44. PubMed ID: 8954171
[TBL] [Abstract][Full Text] [Related]
8. Thrombin enhances the adhesion and migration of human colon adenocarcinoma cells via increased beta 3-integrin expression on the tumour cell surface and their inhibition by the snake venom peptide, rhodostomin.
Chiang HS; Yang RS; Huang TF
Br J Cancer; 1996 Apr; 73(7):902-8. PubMed ID: 8611404
[TBL] [Abstract][Full Text] [Related]
9. Adhesive receptors expressed by tumor cells and platelets: novel targets for therapeutic anti-metastatic strategies.
Oleksowicz L; Dutcher JP
Med Oncol; 1995 Jun; 12(2):95-102. PubMed ID: 8535667
[TBL] [Abstract][Full Text] [Related]
10. Intracellular mediators regulate CD2 lateral diffusion and cytoplasmic Ca2+ mobilization upon CD2-mediated T cell activation.
Liu SJ; Hahn WC; Bierer BE; Golan DE
Biophys J; 1995 Feb; 68(2):459-70. PubMed ID: 7696499
[TBL] [Abstract][Full Text] [Related]
11. Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis.
Weiss L; Orr FW; Honn KV
Clin Exp Metastasis; 1989; 7(2):127-67. PubMed ID: 2465861
[TBL] [Abstract][Full Text] [Related]
12. Lipoxygenase metabolites of arachidonic and linoleic acids modulate the adhesion of tumor cells to endothelium via regulation of protein kinase C.
Liu B; Timar J; Howlett J; Diglio CA; Honn KV
Cell Regul; 1991 Dec; 2(12):1045-55. PubMed ID: 1801923
[TBL] [Abstract][Full Text] [Related]
13. In vitro studies of deformation and adhesion properties of transformed cells.
Anderson KW; Li WI; Cezeaux J; Zimmer S
Cell Biophys; 1991 Apr; 18(2):81-97. PubMed ID: 1726528
[TBL] [Abstract][Full Text] [Related]
14. Platelets and cancer metastasis: a causal relationship?
Honn KV; Tang DG; Crissman JD
Cancer Metastasis Rev; 1992 Nov; 11(3-4):325-51. PubMed ID: 1423821
[TBL] [Abstract][Full Text] [Related]
15. Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin alpha IIb beta 3 and tumor-cell-induced platelet aggregation.
Timar J; Chopra H; Rong X; Hatfield JS; Fligiel SE; Onoda JM; Taylor JD; Honn KV
J Cancer Res Clin Oncol; 1992; 118(6):425-34. PubMed ID: 1377695
[TBL] [Abstract][Full Text] [Related]
16. Is there a role for the tumor cell integrin alpha IIb beta 3 and cytoskeleton in tumor cell-platelet interaction?
Chopra H; Timar J; Rong X; Grossi IM; Hatfield JS; Fligiel SE; Finch CA; Taylor JD; Honn KV
Clin Exp Metastasis; 1992 Mar; 10(2):125-37. PubMed ID: 1371433
[TBL] [Abstract][Full Text] [Related]
17. Role of tumor cytoskeleton and membrane glycoprotein IRGpIIb/IIIa in platelet adhesion to tumor cell membrane and tumor cell-induced platelet aggregation.
Chopra H; Hatfield JS; Chang YS; Grossi IM; Fitzgerald LA; O'Gara CY; Marnett LJ; Diglio CA; Taylor JD; Honn KV
Cancer Res; 1988 Jul; 48(13):3787-800. PubMed ID: 2837325
[TBL] [Abstract][Full Text] [Related]
18. An in vivo study of the role of the tumor cell cytoskeleton in tumor cell-platelet-endothelial cell interactions.
Chopra H; Fligiel SE; Hatfield JS; Nelson KK; Diglio CA; Taylor JD; Honn KV
Cancer Res; 1990 Dec; 50(23):7686-96. PubMed ID: 2253213
[TBL] [Abstract][Full Text] [Related]
19. Platelet enhancement of tumor cell adhesion to subendothelial matrix: role of platelet cytoskeleton and platelet membrane.
Menter DG; Sloane BF; Steinert BW; Onoda J; Craig R; Harkins C; Taylor JD; Honn KV
J Natl Cancer Inst; 1987 Nov; 79(5):1077-90. PubMed ID: 3479634
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
